MX2019010370A - Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados. - Google Patents

Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados.

Info

Publication number
MX2019010370A
MX2019010370A MX2019010370A MX2019010370A MX2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A
Authority
MX
Mexico
Prior art keywords
purified
compositions
cannabinoids
terpenes
compositions comprise
Prior art date
Application number
MX2019010370A
Other languages
English (en)
Inventor
Michael Cooper Jonathan
Levy Kurt
Reed Martin Jonathan
Geoffrey Reid Brian
Original Assignee
Canopy Growth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/616,874 external-priority patent/US20170266153A1/en
Application filed by Canopy Growth Corp filed Critical Canopy Growth Corp
Publication of MX2019010370A publication Critical patent/MX2019010370A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)

Abstract

En este documento se divulgan nuevas composiciones que comprenden un cannabinoide purificado y un terpeno purificado. En una realizacion, las composiciones comprenden uno o mas cannabinoides purificados. En una realizacion, las composiciones comprenden uno o mas cannabinoides purificados en combinacion con uno o mas terpenos purificados. En una realizacion, las composiciones comprenden proporciones no naturales. En una realizacion, las composiciones comprenden concentraciones no naturales. En una realizacion, las composiciones comprenden efectos inesperados y/o sinergicos.
MX2019010370A 2017-03-01 2018-03-01 Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados. MX2019010370A (es)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US201762465688P 2017-03-01 2017-03-01
US201762469415P 2017-03-09 2017-03-09
US201762475153P 2017-03-22 2017-03-22
US201762477990P 2017-03-28 2017-03-28
US201762489360P 2017-04-24 2017-04-24
US201762490567P 2017-04-26 2017-04-26
US201762490465P 2017-04-26 2017-04-26
US201762491175P 2017-04-27 2017-04-27
US201762491160P 2017-04-27 2017-04-27
US201762491899P 2017-04-28 2017-04-28
US201762491980P 2017-04-28 2017-04-28
US201762509651P 2017-05-22 2017-05-22
US201762510229P 2017-05-23 2017-05-23
US201762510660P 2017-05-24 2017-05-24
US201762510672P 2017-05-24 2017-05-24
US201762511218P 2017-05-25 2017-05-25
US15/616,874 US20170266153A1 (en) 2015-02-27 2017-06-07 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
PCT/US2018/020440 WO2018160827A1 (en) 2017-03-01 2018-03-01 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes

Publications (1)

Publication Number Publication Date
MX2019010370A true MX2019010370A (es) 2019-10-22

Family

ID=63370542

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019010370A MX2019010370A (es) 2017-03-01 2018-03-01 Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados.

Country Status (10)

Country Link
EP (1) EP3589129A4 (es)
CN (1) CN110582206A (es)
AU (1) AU2018227544A1 (es)
BR (1) BR112019018088A2 (es)
CA (1) CA3054690A1 (es)
CO (1) CO2019009413A2 (es)
IL (1) IL268929A (es)
MX (1) MX2019010370A (es)
PE (1) PE20200383A1 (es)
WO (1) WO2018160827A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019147690A1 (en) 2018-01-23 2019-08-01 High Sierra Technologies, Inc. Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons
IL266151A (en) * 2019-04-18 2019-07-31 Kanabo Res Ltd Dilute for the cannabinoid preparations
WO2021012044A1 (en) 2019-07-22 2021-01-28 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
JP2023508257A (ja) * 2019-11-26 2023-03-02 ライコレッド リミテッド． カンナビノイドおよびリコピンの抗炎症性の相乗的組み合わせ
CN115605289A (zh) * 2020-04-29 2023-01-13 利加尔有限合伙公司（Nz） 印迹聚合物及其使用方法
EP4188915A1 (en) * 2020-07-27 2023-06-07 Canopy Growth Corporation Methods of synthesizing cannabielsoin and analogs thereof
WO2022165165A1 (en) * 2021-01-29 2022-08-04 The Johns Hopkins University Limonene effects on tetrahydrocannabinol (thc)-induced anxiety
CN113368086B (zh) * 2021-08-11 2021-12-03 龙麻(上海)医药研发有限责任公司 一种***素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
WO2023245185A1 (en) * 2022-06-17 2023-12-21 New Growth Brands, Inc. Compositions comprising cannabinoids and methods of preparation and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
TWI583374B (zh) * 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物***素次***二酚（ｃｂｄｖ）來治療癲癇之用途
ES2784229T3 (es) * 2013-11-20 2020-09-23 Panag Pharma Inc Composiciones y procedimientos para el tratamiento de la inflamación y el dolor ocular
MX2017010872A (es) * 2015-02-27 2018-05-07 Ebbu Llc Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.

Also Published As

Publication number Publication date
WO2018160827A1 (en) 2018-09-07
PE20200383A1 (es) 2020-02-24
BR112019018088A2 (pt) 2020-03-24
EP3589129A1 (en) 2020-01-08
CO2019009413A2 (es) 2019-09-09
AU2018227544A1 (en) 2019-08-29
IL268929A (en) 2019-10-31
CA3054690A1 (en) 2018-09-07
EP3589129A4 (en) 2020-11-25
CN110582206A (zh) 2019-12-17

Similar Documents

Publication Publication Date Title
MX2019010370A (es) Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados.
MX2017010872A (es) Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.
EP3687527A4 (en) COMPOSITIONS CONSISTING OF CANNABIDIOL, TETRAHYDROCANNABINOL, TERPENES AND FLAVONOIDS AND THEIR USE IN THE TREATMENT OF INSOMNIA
JOP20170055B1 (ar) تركيبة شراب تحتوي على اليولوز وطعام يحتوي على التركيبة
WO2017083363A9 (en) Natural preservatives and antimicrobial agents, including compositions thereof
WO2021217004A3 (en) Methods and compositions for treating virus-associated inflammation
EP3758671A4 (en) NATURAL 1,2-ALKANEDIOLS, COMPOSITIONS WITH NATURAL 1,2-ALKANEDIOLS AND PROCESS FOR THEIR PRODUCTION
SG10201808151RA (en) Cortistatin analogues and syntheses and uses thereof
MY185981A (en) Glycoside compositions
CL2008001755A1 (es) Metodo para reducir efectos de deterioro asociado con pesticidas, fertilizantes o una combinacion de los mismos en una planta que comprende el tratamiento con al menos un compuesto derivado de ciclopropeno.
MX2017012803A (es) Produccion de poliuretanos de bajas emisiones.
MX2019010950A (es) Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso.
WO2018127612A3 (en) Compositions comprising lespedeza plant extract
MX2016012559A (es) Composiciones de protector solar.
UY38284A (es) Composiciones y métodos para agonizar el receptor cb2
GB201901099D0 (en) Methods, uses and compositions
MX2017013278A (es) Odorante osmanthus.
MX2020010424A (es) Comprimido o composicion que contiene n-acil etanolamina y cannabinoides.
CO2017004809A2 (es) Composiciones de triptamidas
IL270833B (en) Synergistic preparations containing (r)-dimiracetam (1) and (s)-dimidacetam (2) in a non-sequential ratio
MX2020001992A (es) Peliculas acrilicas quebradizas y etiquetas para la prevencion de la falsificacion que comprenden las mismas.
MX2019009200A (es) Composiciones y métodos para inhibir el reticulón 4.
MX2019013642A (es) Compuestos, composiciones y metodos.
MX2018007398A (es) Composicion para mejorar la sensacion bucal.
MX2018008376A (es) Composiciones de fragancia de liberacion prolongada.